Molecular diagnostics in cancer patients with suspected respiratory mold infections
Journal of Clinical Microbiology · 2025
DOI: 10.1128/jcm.01201-25 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Clinical Microbiology, 2025. Verfasst von V Rickerts und 23 weiteren Autor:innen. Beteiligte Einrichtung: Robert Koch-Institut, Unit 16: Mycotic and Parasitic Agents and Mycobacteria, Berlin, Germany. Hauptthemen laut MEDLINE: Neoplasms, Molecular Diagnostic Techniques, Respiratory Tract Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wilhelm Sander-Stiftung.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Invasive fungal infections (IFIs), including aspergillosis and mucormycosis, are serious complications in cancer patients. Reliable detection of etiologic agents is challenging but important for optimal patient management. In a prospective multicenter study, we compared fungal detection by culture, specific and unspecific qPCRs, and fluorescence in situ hybridization (FISH) targeting Aspergillus and Mucorales in bronchoalveolar lavage fluid (BALF) and serum of adult cancer patients with suspected fungal pneumonia. In subgroups of patients, fungal DNA was amplified from serum. We evaluated 210 IFI episodes (proven: 3, probable: 72, possible: 107, unclassifiable: 28). Broad-range fungal PCR from BALF was terminated early due to frequent amplification of colonizing yeasts. Specific qPCR assays targeting molds ( Aspergillus, Mucorales) were superior for mold detection (26%) compared to FISH (15%) and culture (8%). Detection of fungi by FISH predicted subsequent fungal culture positivity. In proven/probable IFI episodes, detection of Aspergillus DNA was more likely in BALF than in serum (35/75 [47%] vs 11/66 [17%]; P = 0.0002) in contrast to Mucorales DNA (7/75 [9%] vs 5/66 [8%]; P = 0.73). Mucorales DNA was detected together with Aspergillus DNA in 6 of 7 BALF samples but not in serum. Specific qPCRs targeting Aspergillus and Mucorales from BALF are the most sensitive means to identify molds in adult cancer patients with suspected fungal pneumonia. BALF qPCRs suggest frequent fungal coinfection, while viruses were rarely detected. Fungal detection by FISH may predict subsequent positive fungal cultures. IMPORTANCE Mold pneumonia is a serious complication in cancer patients. Reliable detection of etiologic agents is critical for patient care, but optimal testing strategies are undefined. We performed a prospective study comparing molecular tests (specific and unspecific qPCR and FISH) and culture on bronchoalveolar lavage fluid (BALF) and serum, focusing on aspergillosis and mucormycosis to gain insights into mold detection in high-risk patients. We demonstrate that FISH visualizes fungal elements in BALF, predominantly conidia, suggesting recent fungal exposure or failure to clear inhaled conidia at the time of diagnostic testing. We find that specific qPCRs from BALF are the most sensitive method to detect Aspergillus and Mucorales, superior to broad-range qPCR, culture, and testing of serum. Importantly, Mucorales DNA is mostly co-detected with Aspergillus , suggesting co-infections. Although DNA detection in serum is more likely in mucormycosis than in aspergillosis, sole serum testing may miss mucormycosis, precluding optimal patient care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Robert Koch-Institut, Unit 16: Mycotic and Parasitic Agents and Mycobacteria, Berlin, Germany.
- Medizinische Klinik und Poliklinik II, Wü4i, Würzburg University Hospital, Würzburg, Bayern, Germany.
- Department of Hematology, Medical Oncology, and Pneumology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany.
- Medical Clinic 2, Goethe University Frankfurt, Frankfurt, Hessen, Germany.
- Robert Koch-Institut, Unit 37: Healthcare-Associated Infections, Surveillance of Antibiotic Resistance and Consumption, Berlin, Germany.
- Department of Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Nordrhein Westfalen, Germany.
ORCID-Profile: V Rickerts, J Steinmann, J Held, J Löffler
Förderung
- Wilhelm Sander-Stiftung
Zitieren
APA
Rickerts, V., Springer, J., Gerkrath, J., Korczynski, D., Kessel, J., Wieters, I., Liebregts, T., Steinmann, J., Cornely, O. A., Koehler, P., Schwartz, S., Elgeti, T., Meintker, L., Krause, S. W., Held, J., Heinz, W. J., Willinger, B., Maschmeyer, G., Voigt, S., …, & Löffler, J. (2025). Molecular diagnostics in cancer patients with suspected respiratory mold infections. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01201-25
Vancouver
Rickerts V, Springer J, Gerkrath J, Korczynski D, Kessel J, Wieters I, et al. Molecular diagnostics in cancer patients with suspected respiratory mold infections. Journal of Clinical Microbiology. 2025. doi:10.1128/jcm.01201-25
BibTeX
@article{Rickerts2025,
author = {Rickerts, V and Springer, J and Gerkrath, J and Korczynski, D and Kessel, J and Wieters, I and Liebregts, T and Steinmann, J and Cornely, O A and Koehler, P and Schwartz, S and Elgeti, T and Meintker, L and Krause, S W and Held, J and Heinz, W J and Willinger, B and Maschmeyer, G and Voigt, S and Reiche, J and Vehreschild, J J and Einsele, H and Teschner, D and Löffler, J},
title = {Molecular diagnostics in cancer patients with suspected respiratory mold infections},
journal = {Journal of Clinical Microbiology},
year = {2025},
doi = {10.1128/jcm.01201-25}
}
EUVIMED